Sentences with phrase «studies psychedelic drugs»

Not exact matches

Other charities that have benefited from the organization include healthcare outsourcing platform Watsi; The Water Project; the Electronic Frontier Foundation digital - rights activism group; MAPS, an organization that studies therapeutic uses of psychedelic drugs and marijuana; the medical nonprofit SENS Research Foundation; and charity: water.

In the current climate, the main source of funding for studies of hallucinogens are two private philanthropies: the Heffter Research Institute in Santa Fe, which was founded in 1993 by academics and mental health professionals to finance scholarly research, and MAPS (Multidisciplinary Association for Psychedelic Studies), which has dispensed more than $ 10 million since it was launched in 1986 by Rick Doblin, a drug reform activist in Boston with a Harvard University Ph.D. in public studies of hallucinogens are two private philanthropies: the Heffter Research Institute in Santa Fe, which was founded in 1993 by academics and mental health professionals to finance scholarly research, and MAPS (Multidisciplinary Association for Psychedelic Studies), which has dispensed more than $ 10 million since it was launched in 1986 by Rick Doblin, a drug reform activist in Boston with a Harvard University Ph.D. in public Studies), which has dispensed more than $ 10 million since it was launched in 1986 by Rick Doblin, a drug reform activist in Boston with a Harvard University Ph.D. in public policy.

In the heady postwar years, hundreds of promising studies were conducted in the United States, Canada, and Europe on the use of LSD and other psychedelics, like peyote, to treat such psychiatric maladies as schizophrenia, autism, drug addiction, alcoholism, and chronic depression.

«If you were to develop a drug to treat PTSD, you'd want it to do exactly what MDMA does,» says Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), which funds and conducts the research.

The 21 - patient study, sponsored by the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS), launched in 2004 as the first U.S. clinical trial of a psychedelic drug iPsychedelic Studies (MAPS), launched in 2004 as the first U.S. clinical trial of a psychedelic drug ipsychedelic drug in 35 years.

Halpern and Pope won grants for their project not only from the National Institute on Drug Abuse but also from Harvard Medical School and two private foundations that support research on psychedelics: the Multidisciplinary Association for Psychedelic Studies and the Heffter Research Institute (named after the German chemist who isolated mescaline from peyote and discovered its psychoactive properties in the late 1800s).

«While not a clinical trial, this study, in stark contrast to prevailing attitudes that views these drugs as harmful, speaks to the public health potential of psychedelic medicine,» says Assoc. Prof. Zach Walsh, the co-director for UBC Okanagan's Centre for the Advancement of Psychological Science and Law.

They also included, in the mid-1900s, the powerful psychedelic compound lysergic acid diethylamide, or LSD, that is still being studied and has been widely used as an illegal recreational drug.

Now, researchers who've studied how perceptions of meaning change when people take the psychedelic drug known as LSD have traced that sense of meaningfulness to particular neurochemicals and receptors in the brain.

The UBC Okanagan study found that 42 per cent of U.S. adult male inmates who did not take psychedelic drugs were arrested within six years for domestic battery after their release, compared to a rate of 27 per cent for those who had taken drugs such as LSD, psilocybin (commonly known as magic mushrooms) and MDMA (ecstasy).

For their part, Carhart - Harris and his team are keen to study other types of psychedelic drugs, including dimethyltryptamine (DMT), sometimes found in a traditional South American brew called ayahuasca.

New studies — prompted by a renewed interest in potential applications of psychedelic drugs for understanding the brain or even treating some psychiatric diseases — suggest that far - reaching changes in brain connectivity contribute to the altered states of consciousness and other effects of an acid trip.

According to Dr. Vollenweider, who has conducted brain - imaging studies on the effects of psychedelics and MDMA, these drugs appear to affect levels of serotonin and other chemicals in the body and brain that help regulate mood.

The new wave of research on psychedelics — «version 2.0,» as Dr. Ross calls it — began in the early 1990s, when the Food and Drug Administration (FDA) sanctioned a few preliminary studies on psilocybin and MDMA.

Dr. John Krystal, chair of Yale University's department of psychiatry, said the study authors «are very sophisticated in their understanding of psychedelic drugs.»

The non-profit leading the research, the Multidisciplinary Association for Psychedelic Studies (MAPS), is seeking $ 25 mln in donations for Phase 3 of their drug trials.

MAPS believes studies with marijuana and psychedelics can lead to better cures and a greater understanding of these types of drugs.

The patients in the study were given a number of bizarre treatments, including psychedelic drugs such as LSD and participating in naked encounter groups, in an effort to break down their defenses.